Chromadex Debt 2024

Chromadex Debt

-27.15 USD

Chromadex Dividend yield

Ticker

CDXC

ISIN

US1710774076

WKN

A2AG5N

In 2024, Chromadex's total debt was -27.15 USD, a 34.41% change from the -20.2 USD total debt recorded in the previous year.

Chromadex Aktienanalyse

What does Chromadex do?

The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Chromadex's Debt Structure

Chromadex's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Chromadex's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Chromadex’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Chromadex’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Chromadex Stock

What is the debt of Chromadex this year?

Chromadex has a debt level of -27.15 USD this year.

What was the debt of Chromadex compared to the previous year?

The debt of Chromadex has increased by 34.41% compared to the previous year increased.

What are the consequences of high debt for investors in Chromadex?

High debt can pose a risk for investors of Chromadex, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Chromadex?

Low debt means that Chromadex has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Chromadex affect the company?

An increase in debt of Chromadex can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Chromadex affect the company?

A reduction in debt of Chromadex can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Chromadex?

Some factors that can influence the debt of Chromadex include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Chromadex so important for investors?

The debts of Chromadex are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Chromadex take to change the debt?

To change the debt, Chromadex can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Chromadex pay?

Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.

What is the dividend yield of Chromadex?

The current dividend yield of Chromadex is .

When does Chromadex pay dividends?

Chromadex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chromadex?

Chromadex paid dividends every year for the past 0 years.

What is the dividend of Chromadex?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chromadex located?

Chromadex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chromadex from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Chromadex pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Chromadex in the year 2023?

In the year 2023, Chromadex distributed 0 USD as dividends.

In which currency does Chromadex pay out the dividend?

The dividends of Chromadex are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Chromadex stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Chromadex

Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.